PSI

Injectable Contraception

Progestin-only injectable contraceptives (PICs) are a highly effective, safe, and convenient method of contraception that should be made available as a choice to couples in need of family planning.

Injectables are the fourth most popular method worldwide, after female sterilization, the intrauterine device (IUD), and oral contraceptives. In sub-Saharan Africa, injectables are the most popular method, chosen by 38% of women using modern methods. By 2015 worldwide use is projected to reach nearly 40 million—more than triple the 1995 level. In 2008 alone, PSI's social marketing programs worldwide generated nearly 1.4 million couple years of protection (CYPs) from PICs.

In December 1995, PSI launched its first progesterone-only injectable contraceptive social marketing programs in Guinea and Nigeria. PSI now markets PICs in Benin, Cambodia, Cameroon, DRC Congo, Haiti, India, Kenya, Madagascar, Malawi, Mali, Myanmar, Nicaragua, Nigeria, Pakistan, Rwanda, Togo, Zambia and Zimbabwe, having provided over 1.7 million CYPs since 1995.

Archived in
Health Areas: Reproductive Health